cagrisema vs retatrutide CagriSema: The Battle Nobody's Covering The Obesity Wars of 2026

This can indicate growing anxiety about appearance rather than a neutral focus on health

Retatrutide (LY3437943) is an investigational triple hormone receptor agonist developed by Eli Lilly

For the right patient, medications such as semaglutide and tirzepatide may reduce appetite, quiet food noise, improve satiety, support blood sugar regulation, and help create meaningful weight loss when paired with nutrition, activity, and medical follow-up

"I'm on some peptides myself," said Dr

Amie Hornaman, author of the bestselling book The Thyroid Fix, to learn what could really be causing fatigue, weight gain, and low energy and why you may need to address your thyroid health before considering GLP-1 medications